1. Long-term experience with endovascular therapy of the descending thoracic aorta.
- Author
-
Raupach, Jan, Vojacek, Jan, Lojik, Miroslav, Harrer, Jan, Chovanec, Vendelin, Ferko, Alexander, Hoffmann, Petr, Ryška, Pavel, Renc, Ondrej, and Krajina, Antonin
- Subjects
ENDOVASCULAR surgery ,THORACIC aorta ,DEATH rate ,CAUSES of death ,FOLLOW-up studies (Medicine) ,SURGICAL stents ,SURGERY - Abstract
Background: To review single centre experience of endovascular treatment of descending thoracic aorta. Methods: Between May 1999 and September 2012, 72 patients were treated overall (53 men, 19 women, mean age 60.1 years) for degenerative aneurysms (n = 5), ruptured aneurysms (n = 4), aortic ulcers (n = 8), infected aneurysms (n = 4), type B aortic dissections (n = 23), and traumatic aortic injuries (n = 28). Results: The technical success rate was 98.6%, 30-day mortality was 8.3%, 1-year mortality was 13.8%, and overall mortality was 22.2%. Mortality caused by the treatment of aortic diseases was 6.9%. Permanent stroke occurred in 1 patient, and paraplegia developed in 1 patient. In a group of 23 patients whose left subclavian artery (LSA) was covered, claudication of the left upper extremity developed in 2 cases. Conclusions: Endovascular therapy offers a very effective and less invasive alternative to the surgical approach for a wide range of the thoracic aortic disease. The main advantage of using TEVAR seems to be in acute conditions when a stent graft stabilizes the aorta and prevents further bleeding and organ ischemia. Regular follow-up is mandatory for early recognition of specific TEVAR complications. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF